Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Non-Current Assets (2019 - 2025)

Outset Medical (OM) has disclosed Non-Current Assets for 7 consecutive years, with $13.6 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 22.54% to $13.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $53.4 million through Dec 2025, down 29.25% year-over-year, with the annual reading at $13.6 million for FY2025, 22.54% down from the prior year.
  • Non-Current Assets for Q4 2025 was $13.6 million at Outset Medical, up from $11.9 million in the prior quarter.
  • The five-year high for Non-Current Assets was $58.1 million in Q1 2021, with the low at $11.9 million in Q3 2025.
  • Average Non-Current Assets over 5 years is $32.1 million, with a median of $24.4 million recorded in 2023.
  • The sharpest move saw Non-Current Assets increased 0.39% in 2022, then crashed 57.33% in 2023.
  • Over 5 years, Non-Current Assets stood at $53.7 million in 2021, then crashed by 50.67% to $26.5 million in 2022, then fell by 14.69% to $22.6 million in 2023, then fell by 22.18% to $17.6 million in 2024, then decreased by 22.54% to $13.6 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $13.6 million, $11.9 million, and $13.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.